Alpha1Health.com | Information for the New Alpha-1 Patient | Newly Diagnosed With Alpha-1

Newly Diagnosed with Alpha-1

*Also known as alpha-1 antitrypsin deficiency, AAT deficiency, AATD, A1-PI deficiency, alpha-1 antiprotease deficiency, A1AD, or hereditary or genetic emphysema.

Alpha1Health.com is here to help you with every step and stage of life with Alpha-1. We invite you to visit other sections of our website to learn more.

Here are some good starting points:

ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information

adobe reader To view PDF, you will need Adobe® Acrobat® Reader® software.